molluscum%20contagiosum
MOLLUSCUM CONTAGIOSUM
Molluscum contagiosum is an infection due to poxvirus that results into discrete skin lesions with central umbilication.
Spread is by skin-to-skin contact, fomites spread and autoinoculation.
Patients with atopic dermatitis, HIV or immunodeficiency are particularly susceptible.
Incubation period may be from 2-7 weeks.
In children, it usually presents with lesions on the face, scalp, ears, trunk and extremities and crural folds while in adults, it is typically sexually transmitted and affects the groin, genital area, thighs and lower abdomen.

Introduction

  • Molluscum Contagiosum (MC) is an easily transmissible poxvirus
    • Spread is by skin-skin contact, fomites spread & autoinoculation
    • Patients w/ atopic dermatitis, HIV or immunodeficiency are particularly susceptible
  • Incubation may be from 2-7 wk

Signs and Symptoms

Clinical Presentation

Children

  • Usually present w/ lesions on the face, scalp, ears, trunk & extremities (axilla, antecubital, popliteal fossa) & crural folds
    • Genital presentation may have occurred from autoinoculation

Adults

  • MC is typically sexually-transmitted
  • MC affects the groin, genital area, thighs & lower abdomen
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Infectious Diseases - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Tristan Manalac, 5 days ago
Incorporating genotyping of human adenovirus (HAdV) infections in clinical practice may inform risk stratification and treatment decisions, according to a new Singapore study.
Tristan Manalac, 25 Oct 2019
Old age and lower white cell counts are significant risk factors for poor platelet recovery among dengue patients with thrombocytopaenia, according to a recent Singapore study.
3 days ago
A 10-day or 14-day sequential therapy strategy is more cost-effective than a conventional triple therapy in the management of patients with Helicobacter pylori infection, in addition to being more effective in terms of eradication of infection, as reported in a study from Egypt.
Tristan Manalac, 04 Sep 2019
A booster injection of CYD-TDV (Dengvaxia) can generally restore antidengue antibody titres 5 years after a three-dose schedule, according to a new Singapore study.